Teeth capable of preserving antibodies for centuries, study finds
A new study has found that teeth could preserve antibodies for hundreds of years, allowing scientists to better understand the history of infectious diseases. Researchers
A new study has found that teeth could preserve antibodies for hundreds of years, allowing scientists to better understand the history of infectious diseases. Researchers

A study led by the University of Birmingham of more than a thousand dental professionals has shown their increased occupational risk of SARS-CoV-2 infection during

As most dental practices close out the year, we’re doing everything possible to complete our treatment plans for our lucky insured patients with jobs. With

A survey of nearly a thousand people who were tested for COVID-19 at the University of Michigan School of Dentistry this summer examined how the

The University of California Los Angeles (UCLA) School of Dentistry has received $300,000 to develop and clinically validate a rapid response, saliva-based test to detect

Peter Burbelo, PhD, of the National Institute of Dental and Craniofacial Research (NIDCR) is taking his earlier research into Sjögren’s syndrome and developing a new

Researchers at the University of Saskatchewan College of Dentistry will use more than $550,000 in funding from the Canadian Institutes of Health Research (CIHR) to

Oral biologist Vincent K. Tsiagbe, MS, PhD, of the Rutgers School of Dental Medicine has received a United States patent for a method of detecting cancer

African American women with poor oral health may be more likely to get pancreatic cancer, according to researchers at Boston University’s Slone Epidemiology Center. Previous
As 70 countries and territories have reported evidence of mosquito-borne Zika transmission, researchers from the University of Western Ontario and the University of Sao Paulo
Porphyromonas gingivalis, a bacterium associated with periodontal diseases, also may delay conception in young women, according to the University of Helsinki. The study comprised 256
A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to the Abramson Cancer Center of